David S. Smith, of counsel in Pepper Hamilton’s Health Sciences Department, has been named to the 2018 class of International Fellows of Tissue Engineering and Regenerative Medicine (FTERM) by the Governing Board of the Tissue Engineering and Regenerative Medicine International Society (TERMIS). He is the only attorney to be selected as a member of FTERM.
TERMIS was founded in 1994 as the Tissue Engineering Society, the first international scientific society for the then-emerging field of regenerative medicine. Today, TERMIS has more than 4,600 members around the world. It established FTERM in 2011 to recognize academicians, physicians and other leaders who have made significant contributions to the development and promotion of this scientific discipline and the breakthrough biomedical therapies it is enabling. FTERM is presently composed of 40 fellows. Every three years, TERMIS identifies a new class of fellows to join this elite group in recognition of their formative roles in shaping the tissue engineering and regenerative medicine field and TERMIS.
Mr. Smith, a corporate lawyer focused on intellectual property transactions, venture financings and regulatory matters for life sciences companies and investors, is an authority on the legal issues surrounding the use of human biological materials. He has significant experience in the areas of tissue engineering and regenerative medicine, including serving on the executive committee of TERMIS and as secretary of the Pittsburgh Tissue Engineering Initiative.
The 2018 FTERM class will be recognized at the TERMIS World Congress in Kyoto, Japan, on September 5.
To accomplish its mission, the Tissue Engineering and Regenerative Medicine International Society brings together the international community of persons engaged or interested in the field of tissue engineering and regenerative medicine and promotes education and research within the field of tissue engineering and regenerative medicine through regular meetings, publications and other forms of communication. The Society also serves as an international forum to promote the informed discussion of challenges and therapeutic benefits of the application of tissue engineering and regenerative medicine technologies.